What's new at Xpedite Diagnostics?

Good news for all who are looking for a rapid yet sensitive DNA extraction solution for infectious disease testing. Here it is: SwiftX™ ParaBact!

Last week we hosted a customer who is aiming to utilize our mobile molecular laboratory for environmental testing.

Xpedite Diagnostics has moved to it's new headquarter in the Munich Airport Business Park in Hallbergmoos, which is just 10 minutes away from the airport.

Xpedite Diagnostics signed agreement for development of a tailored nucleic acid extraction solution.

Xpedite Diagnostics was granted funding of 145K Euro by the German Federal Ministry of Education and Research within the joint research project "DiagnoSeps".

Xpedite Diagnostics has attended the first WHO meeting on neglected tropical diseases (NTDs) of the skin. Our founder, Dr. Andy Wende, has been given the opportunity to present the company and our SwiftX technology.

This week's webinar of the ISNTD was dedicated to Schistosomiasis. Xpedite Diagnostics presented its new mobile molecular laboratory and SwiftX DNA.

A British-Brazilian research group published the first peer-reviewed paper about their work utilizing a SwiftX extraction kit by Xpedite Diagnostics.

Xpedite Diagnostics presented a round-up on nucleic acid extraction with all its aspects and a detailed view on fast nucleic acid extraction for point-of-care applications.

Xpedite Diagnostics received the grant notice of the Bavarian State Ministry for a proposal on an project on applied molecular diagnostics research.